Phase I / II multicenter, randomized and controlled clinical trial to evaluate the efficacy of treatment with hyperimmune plasma obtained from patients convalescing from COVID-19 infection.
- Funded by Junta de Andalucia
- Total publications:0 publications
Grant number: COVID-0008-2020
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$87,340Funder
Junta de AndaluciaPrincipal Investigator
Jesús Rodríguez Baño, Salvador Oyonarte Gómez, Julian Olalla Sierra, Salvador López Cárdenas, Jose Antonio Girón González, Alberto Romero Palacios, Ismael Aomar Millán, Inmaculada Poyato Ayuso, Jesús Santos González, Concepción López Robles, Juan Macías Sánchez…Research Location
SpainLead Research Institution
Fundación Promoción SocialResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Phase 1 clinical trial
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Clinical Trial, Phase I
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified